Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(methylsulfonyl)propanenitrile
2. Olt-1177
3. Olt117
4. Olt1177
1. 54863-37-5
2. 3-methanesulfonylpropanenitrile
3. 3-(methylsulfonyl)propanenitrile
4. Olt1177
5. Olt-1177
6. Dapansutrile [inn]
7. 3-methylsulfonylpropionitrile
8. 3-methylsulfonylpropanenitrile
9. 3-(methanesulfonyl)propanenitrile
10. Propanenitrile, 3-(methylsulfonyl)-
11. 2z03364g96
12. Dapansutrile(olt1177)
13. Dapansutrile (usan/inn)
14. Dapansutrile [usan:inn]
15. Dapansutrile [usan]
16. Dapansutrile (olt1177)
17. Dapansutrile [who-dd]
18. 3-methylsulphonyl-propionitrile
19. Schembl9934796
20. Chembl3989943
21. Gtpl10056
22. Dtxsid601336541
23. Unii-2z03364g96
24. Ex-a4519
25. Bdbm50505850
26. S8907
27. Zinc32005410
28. Akos010140086
29. Ac-36465
30. Bs-45330
31. Hy-17629
32. Cs-0016785
33. D5955
34. D10920
35. E74469
36. A936206
37. Q27255815
38. Z2719319073
Molecular Weight | 133.17 g/mol |
---|---|
Molecular Formula | C4H7NO2S |
XLogP3 | -0.7 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 133.01974964 g/mol |
Monoisotopic Mass | 133.01974964 g/mol |
Topological Polar Surface Area | 66.3 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 190 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Dapansutrile specifically inhibits the NLRP3 inflammasome and subsequent activation of IL-1. It is currently being investigated against gout flares, joint pain and COVID-19.
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?